NEW ORLEANS, Nov 11 (Reuters) - The blood pressure medicine Avapro, sold by Bristol-Myers Squibb Co and Sanofi-Aventis , was no better than usual care in treating a type of heart failure that ...

Bill to change blood donation rules fails in the Iowa House A bill that would change blood donation rules failed to advance through an Iowa House subcommittee on Tuesday. SF 2369 would have required ...

Poonsawat Kratingdaenggym's attempt to win back the WBA super-bantamweight title suffered a knockout blow on Thursday after he failed pre-fight blood tests. The 32-year-old Thai was scheduled to fight ...

AbbVie (NYSE:ABBV) announced Friday that its FDA-approved blood cancer therapy venetoclax did not reach the primary endpoint in a Phase 3 trial for patients with multiple myeloma as a late-line ...

Could your heart get hooked on blood sugar? Researchers at the University of Virginia School of Medicine think so, and they will determine if blocking that addiction could prevent enlargement of the ...

(Reuters) -GSK's blood cancer drug Blenrep failed the main goal of a late-stage study designed to show it was better than an existing treatment on the market, the company said on Monday. Oncology is a ...

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with low-grade serous ovarian cancer (LGSOC), according to a study. The ...

Here's another vote for less screen time. Using a smartphone application to track blood pressure won't lead to any greater reduction in BP than self-monitoring the old-fashioned way, a new study finds ...